49 unknown. 49 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 49 | Unknown 49 |
Follow Schizophrenia: new trials by email Literature Review of Schizophrenia trials Research Report on Schizophrenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maintenance Electroconvulsive Therapy (ECT) Versus Aripiprazole in Clozapine-resistant Schizophrenia maintenance ECT, Aripiprazole tablet - Clozapine Resistant Schizophrenia | Phase 4 | Unknown | All India Institute of Medical Sciences, Bhubaneswar | 40 | 2024-08-10 | 2024-07-16 |
| Multidisciplinary Design to Optimize Schizophrenia Treatment Based on Multi-omics Data and Systems Biology Analysis Aripiprazole, Paliperidone - Schizophrenia, Treatment-resistant Schizophrenia | Phase 4 | Unknown | Consorcio Centro de Investigación Biomédica en Red (CIBER) | 244 | 2023-11-01 | 2023-09-29 |
| Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder | Phase 4 | Unknown | Temple University | 32 | 2023-07-01 | 2023-10-23 |
| A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia Agomelatine - Schizophrenia, Negative Symptoms in Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 220 | 2023-01-01 | 2022-12-12 |
| Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU) Lurasidone - Schizophrenia | Phase 4 | Unknown | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 10 | 2022-01-26 | 2023-03-17 |
| Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients Berberine, Metformin - Schizophrenia, Metabolic Syndrome | Phase 4 | Unknown | Tianjin Anding Hospital | 100 | 2021-12-01 | 2022-02-16 |
| Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication? Semaglutide, 1.34 mg/mL, Semaglutide-placebo - Metabolic Disturbance, Schizophrenia | Phase 4 | Unknown | Anders Fink-Jensen, MD, DMSci | 104 | 2021-09-01 | 2024-09-25 |
| Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model Building Risperidone, Aripiprazole, Ziprasidone - Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 350 | 2021-05-01 | 2020-08-26 |
| Clozapine Versus Olanzapine as Treatment for Comorbid Psychotic Disorder and Substance Use Disorder Clozapine, Olanzapine - Psychosis, Substance Use Disorders | Phase 4 | Unknown | Augusta University | 100 | 2020-07-01 | 2020-03-23 |
| Comparison of Ketamine Combine Propofol vs Propofol Anesthesia in Schizophrenia Electroconvulsive Therapy Propofol, Ketamine - Schizophrenia | Phase 4 | Unknown | Chang Gung Memorial Hospital | 1 | 2019-05-24 | 2019-05-29 |
| DIMES - DIgital MEdicine Study for Adults With Schizophrenia, Bipolar I Disorder, or Major Depression Currently Using Aripiprazole ABILIFY MYCITE - Schizophrenia, Major Depressive Disorder | Phase 4 | Unknown | Durham VA Medical Center | 46 | 2019-04-04 | 2020-06-18 |
| Anti-inflammatories and Adolescent Schizophrenia Celecoxib 200mg, Placebo oral capsule, Minocycline 100mg - Schizophrenia | Phase 4 | Unknown | Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico | 90 | 2019-02-25 | 2019-09-03 |
| Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia acupuncture, Amisulpride - Schizophrenia | Phase 4 | Unknown | Shanghai Mental Health Center | 50 | 2017-10-01 | 2019-01-14 |
| The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia paliperidone palmitate, control group - Schizophrenia | Phase 4 | Unknown | Maosheng Fang | 150 | 2017-04-01 | 2017-04-25 |
| The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation Ziprasidone - Schizophrenia | Phase 4 | Unknown | Yang Fude | 1000 | 2016-10-01 | 2016-10-18 |
| Adjunctive Vortioxetine in Schizophrenia Vortioxetine, Placebo - Schizophrenia, Negative Symptoms | Phase 4 | Unknown | Northwell Health | 88 | 2016-02-01 | 2024-02-08 |
| A Pharmacokinetic Study of Paliperidone ER Paliperidone ER - Schizophrenia, Schizoaffective Disorder | Phase 4 | Unknown | National Taiwan University Hospital | 40 | 2015-04-01 | 2015-11-23 |
| Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up Aripiprazole, Risperidone - Schizophrenia, Psychotic Disorders | Phase 4 | Unknown | Fundación Marques de Valdecilla | 115 | 2015-01-01 | 2020-01-14 |
| Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia Aripiprazole Once-Monthly, Oral Antipsychotic (i.e. aripiprazole, risperidone, lurasidone, quetiapine, olanzapine, ziprasidone, etc) - Schizophrenia | Phase 4 | Unknown | Matt Byerly | 200 | 2014-12-01 | 2015-06-08 |
| Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-up Aripiprazole, Risperidone - Schizophrenia, Psychotic Disorders | Phase 4 | Unknown | Fundación Marques de Valdecilla | 200 | 2014-06-01 | 2019-07-10 |
Showing 20 of 49. Sign in to see all of them.
Psychotic Disorders (15) · Bipolar Disorder (4) · Cognitive Dysfunction (3) · Depressive Disorder, Major (2) · Diabetes Mellitus (2) · Medication Adherence (2) · Metabolic Syndrome (2) · Psychomotor Agitation (2) · Schizophrenia, Treatment-Resistant (2) · Aggression (1) · Cognition Disorders (1) · Dementia (1) · Diabetes Mellitus, Type 2 (1) · Disease (1)
Schizophrenia Spectrum and Other Psychotic Disorders (49) · Mental Disorders (48) · Pathological Conditions, Signs and Symptoms (7) · Behavior (6) · Nervous System Diseases (6) · Glucose Metabolism Disorders (5) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Bipolar and Related Disorders (4) · Central Nervous System Diseases (4) · Endocrine System Diseases (4) · Neurocognitive Disorders (4) · Signs and Symptoms (4) · Aberrant Motor Behavior in Dementia (3) · Behavioral Symptoms (3)
Aripiprazole (12) · Risperidone (11) · Paliperidone Palmitate (5) · Quetiapine Fumarate (4) · ziprasidone (4) · Amisulpride (3) · Olanzapine (3) · Antipsychotic Agents (2) · Donepezil (2) · Escitalopram (2) · Lurasidone Hydrochloride (2) · Metformin (2) · Minocycline (2) · Acupuncture Therapy (1) · Berberine (1)
Fundación Marques de Valdecilla (3) · Shanghai Mental Health Center (3) · BeerYaakov Mental Health Center (2) · Central South University (2) · National Taiwan University Hospital (2) · University of Sao Paulo (2) · All India Institute of Medical Sciences, Bhubaneswar (1) · Anders Fink-Jensen, MD, DMSci (1) · Augusta University (1) · Bayside Health (1) · CHA University (1) · Chang Gung Memorial Hospital (1) · Consorci Hospitalari de Vic (1) · Consorcio Centro de Investigación Biomédica en Red (CIBER) (1) · Durham VA Medical Center (1)
China (9) · United States (9) · Spain (5) · Israel (4) · Taiwan (4) · Brazil (2) · Canada (2) · Italy (2) · South Korea (2) · Australia (1) · Denmark (1) · Germany (1) · Mexico (1) · Poland (1)
Benedicto Crespo-Facorro, Professor (3) · Anders Fink-Jensen, MD (1) · Christoph U Correll, MD (1) · Gary Hasey, MD (1) · Hayden Bosworth, PhD (1) · Javier Labad Arias, MD, PhD (1) · Jayashri Kulkarni, Prof (1) · Joo-Cheol Shim, MD,PhD (1) · Joseph I Friedman, MD (1) · Lakshmi P Voruganti, MD (1) · Lingjiang Li, MD, PhD (1) · Liu Chih-Min, MD (1)
PMID 16247923, PMID 16499883, PMID 19445659, PMID 19906343, PMID 21508849, PMID 22938760, PMID 23295604, PMID 23422376, PMID 23775051, PMID 25004184, PMID 25934131, PMID 27805978, PMID 33678469, PMID 35894865, PMID 36548028, PMID 36720576, PMID 41335431, PMID 42755522